— Quest Diagnostics (NYSE: DGX) reported third quarter 2019 adjusted EPS of $1.76 vs. $1.71 expected.
Check below Quest Diagnostics Q3 2019 earnings infograph
— GAAP EPS of continuing operations increased 2.8% year-over-year to $1.56.
— Revenue grew 3.5% to $1.96 billion vs. $1.94 billion expected.
— Diagnostic Information Services revenue grew 3.7% to $1.88 billion.
— For fiscal 2019, revenue is expected to be approximately $7.72 billion.
— FY19 adjusted EPS is pegged to be between $6.45 and $6.50. Reported EPS from continuing operations is touted to be $5.48-5.43.
— DGX stock, which reached its 52-week high on Sept. 20, inched down 0.37% to $102.28 yesterday.
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to
